Hi Bill,
I care for a 14 yr old with CML - Rio sometimes posts on this site and has just started his BMT. He was diagnosed nearly 2 years ago and started on Glivec after hydroxyurea treatment. His Glivec dosage started at 200mg and was increased to 300mg in October 2007, then 400mg in Feb 2008. Initially his response was good, but it plateaued without getting to a 3 log reduction and the decision was made to have a transplant. He was offered the opportunity to go on a dasatinib trial but declined - he has consistently said that he wanted to have a transplant and get rid of CML, not to be on medication for CML for the rest of his life. On Glivec he experienced the usual side effects which diminished over a few months, but returned with each dosage increase. He was tired almost all the time. The BMT is from an unrelated 90% matched donor. He has had 4 days chemotherapy and is now having 4 days radiotherapy prior to the transplant on Friday. He was a very fit and healthy young man going into this BMT (apart from the CML!) which stands him in good stead. I am utterly amazed at how well he is after the week of treatment he has had, though I know the worst is yet to come before he gets better.
I hope this is the sort of info you were looking for - the short answer to your question is the course of treatment chosen was the BMT, but as you see, the circumstances make a difference.
Rio has a caringbridge site if you are interested in checking on his progress - he is updating it quite often now the BMT has got under way:
www.caringbridge.org/visit/riowilliams
He loves getting comments in his guestbook!
All the best in your quest for the right treatment for you.
Best wishes
kestrel